AbbVie’s $2.1B Acquisition Adds In Vivo Cell Therapy to Its Immunology & Inflammation Pipeline
AbbVie wasn’t a part of the primary wave of cell therapies developed for most cancers, however it's positioning itself to ...
AbbVie wasn’t a part of the primary wave of cell therapies developed for most cancers, however it's positioning itself to ...
Sage Therapeutics is shedding most of its workers after asserting its deliberate acquisition earlier this month. The Cambridge, Mass.-based biotech agency will ...
Capital Rx, a pharmacy profit supervisor, has acquired care navigation firm Amino Well being, the businesses introduced on Wednesday. New ...
Novartis has made kidney problems an space of focus, and it’s now including a brand new drug prospect by means ...
Bluebird Bio, an organization that steered three gene therapies to FDA approval however struggled to commercialize them, has discovered the ...
Novartis is increasing its prospects in cardiometabolic illness by putting a deal to accumulate Anthos Therapeutics, an organization in pivotal ...
A notable marriage is going on on the earth of digital well being: Transcarent has claimed Accolade for $621 million. ...
Avid Bioservices, a contract growth manufacturing group (CDMO) specializing in biologic medication, goes personal in an M&A deal that values ...
Neuroscience drug developer Lundbeck is increasing its scope to epilepsy through the $2.6 billion acquisition of Longboard Prescribed drugs, an ...
A vaccine panel appointed by Well being Secretary Robert F. Kennedy Jr. voted in opposition to recommending influenza vaccinations containing...
Copyright © 2024 Agarwood Times.
Agarwood Times is not responsible for the content of external sites.
Copyright © 2024 Agarwood Times.
Agarwood Times is not responsible for the content of external sites.